Longevity

Investors

Lunch

Davos, Seehof Hotel
May 25, 2022

Photos & Videos

About

The Longevity Investors Lunch was an invite-only event that created a platform for exclusive networking and sharing insights into new technologies and research, among prominent scientists, academia, entrepreneurs, and  investors. 

The reception brought together 50 VIP guests interested in the longevity-related research and breakthrough technologies and provided latest insights in the longevity field.

The event was open only to institutional investors interested in the Maximon Longevity Co-investment Fund (minimum ticket of CHF 0.5 million).

The Longevity Investors Lunch was organised by Maximon and the Longevity Investors Conference.

Location

The Longevity Investors Lunch took place in the exclusive Hotel Seehof, famous for high-level networking in Davos. 

May 25, 2022
12am - 15pm
Hotel Seehof, 7260 Davos Dorf, Switzerland

Hosts

foto_19_edited.png

Caroline Wagner

Founding Partner at Maximon

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Jörg Rieker

Founding Partner at Maximon

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Marc P. Bernegger

Founding Partner at Maximon

linked+linkedin+logo+social+icon-1320191
Twitter.png

Speakers

foto_19_edited.png

Dmitry Kaminskiy

General Partner at Deep Knowledge Group, innovative entrepreneur, investor, author and philanthropist.

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Thomas Nirnberger

CEO BioFi Virtual Tissue Emulation
Filling in the gap for evidence on the biological mechanism of aging biomarkers (Quant Biomarkers & BioFi example)

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Matthias Steger

Founder and CEO Rejuveron

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Patrick Burgermeister

Partner at KIZOO Technology Capital

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Dr. Dina Radenkovic

Co-founder & CEO of Gameto & Partner, SALT

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Dr. Sanja Tomovska

CEO and Managing Partner Quant Biomarkers

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Nathalie Giroud

Neuropsychologist at University of Zürich & WEF contributor on Healthy Ageing and Longevity

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Sophie Chabloz

CPO at Avea Life

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Dr. Yap Seng Chong

Founding Director of the A*STAR-NUS Singapore Centre for Nutritional Sciences, Metabolic Disease, and Human Development, NUHS

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Prof. Dr. Collin Y. Ewald

Assistant Professor at ETH Zurich. Founder of Swiss Society for Aging Research

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Pascal Kaufmann

Founder and CEO Mindfire

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Dr. Rob Konrad Maciejewski

CEO at Biolytica

linked+linkedin+logo+social+icon-1320191
Twitter.png
 

Program

Post-conference summary

12.00 - 12.30

Welcome drinks

Post-conference summary

12.30 - 12.40

Intro to longevity

Why is longevity the largest investment opportunity in the decades to come?

Post-conference summary

12.40 - 13.05

Panel 1: New mega trends in Technology and Science for Healthy Longevity

Panel discussion with scientists and physicians: Where do we stand in research? The status quo of health extension. Which interventions exist to enhance healthspan?

Post-conference summary

13.05 - 13.15

Keynote presentation by Dmitry Kaminskiy

Dmitry Kaminskiy, General Partner at Deep Knowledge Group will make a Longevity industry overview and talk about the Longevity policy and governance, as well as the Swiss Longevity Valley

Post-conference summary

13.15 - 13.40

Panel 2: Overview of the latest investing activities and investment landscape

Panel discussion with investors: How to invest in longevity: Fund approach and direct investment approach. How to invest in longevity start-ups?

Post-conference summary

13.40-14.00

Closing remarks

Introduction to Maximon ventures and closing remarks

Post-conference summary

14.00-15.00

Networking reception

Longevity Investors Lunch May 25 Davos Speakers.webp
Longevity Investors Lunch May 25 Davos Agenda.webp

Organised by

Maximon.png
Bildschirmfoto 2021-06-07 um 20_14_01.webp

Partners

color black_4x_edited.webp
Deep Knowledge Group_edited.webp